期刊文献+

细胞色素CYP2A6基因多态性与COPD易感性的关系 被引量:1

Association between CYP2A6 polymorphism and susceptibility of chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的探讨细胞色素CYP2A6基因多态性与COPD易感性的关系。方法应用聚合酶链反应-限制性片段长度多态性法(PCR-RFLP)检测40例COPD患者及37例健康体检者静脉血细胞色素P450 2A6位点等位基因和基因型。结果 1.COPD患者CYP2A6-163C>A位点基因缺失型(del)和野生型(wt)基因型频率为17.5%、82.5%,健康对照组分别为40.5%、59.5%,两组基因分布频率差异有统计学意义(χ2=5.000,P=0.025),携带CYP2A6wt基因型者较携带CYP2A6del基因型者患COPD风险增加(OR=0.31,95%CI=0.109-0.886,P<0.05)。2.在吸烟者中,携带CYP2A6wt基因型者较携带CYP2A6del基因型者患COPD风险增加(OR=0.24,95%CI=0.064-0.920,P<0.05),在不吸烟者中,携带CYP2A6wt、CYP2A6del基因型者之间患COPD风险无明显差异。结论 1.CYP2A6-163C>A基因多态性可能是COPD发病的危险因素。2.野生型(wt)可能为吸烟者患COPD的一个易感因素。 Objective To investigate the association between CYP2A6 polymorphism and susceptibility of chronic obstructive pulmonary disease(COPD).Methods 40 COPD patients and 37 healthy people were enrolled in this study,and their venous blood cytochrome P450 2A6 allele and genetic type were detected by PCR-RFLP.Results 1.The genotype frequency of gene deletion type(del) and wild type(wt) on CYP2A6-163C A was 17.5% and 82.5% in COPD patients and 40.5% and 59.5% in the controls respectively.The difference of gene distribution frequency had statistical significance(χ2=5.000,P=0.025).The COPD patients carrying CYP2A6wt genotype had a higher risk than those carrying CYP2A6del genotype did(OR=0.31,95%CI=0.109-0.886,P0.05).2.Smokers carrying CYP2A6wt genotype had a higher risk than those carrying CYP2A6del genotype(OR=0.24,95%CI=0.064-0.920,P0.05).There was no significant difference among nonsmokers.Conclusion 1.The polymorphism of CYP2A6-163CA may be the risk factors causing COPD.2.Wild type(wt) may be a predisposing factor of COPD to smokers.
出处 《临床肺科杂志》 2013年第5期823-825,共3页 Journal of Clinical Pulmonary Medicine
关键词 慢性阻塞性肺病 细胞色素基因 基因多态性 吸烟 COPD cytochrome gene gene polymorphism smoking
  • 相关文献

参考文献10

  • 1Teramoto S. COPD pathogenesis from the viewpoint of risk factors [ J ]. Intern med, 2007,46 ( 2 ) : 77 - 79.
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8234
  • 3Binnington MJ, Zhu AZ, Renner CC,et al. TCYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people [ S ]. Pharmacogenet Genomics, 2012,22(6) :429 -440.
  • 4Wilson R. Bacteria and airway inflammation in chronic obstructive pulmonary disease:more evidence[ J]. Am J Respir Crit Care Med, 2005,172(2) :147 - 148.
  • 5秦军,高媛.吸烟人群COPD遗传易感性差异的内因研究[J].临床肺科杂志,2011,16(7):1083-1084. 被引量:5
  • 6Liang HC, Li H, et al. CYP1A2 ( - / - ) null mutating mice develop normally but show deficient drug metabolism [ J ]. Proc Natl Aead US, 1993,1671 - 1676.
  • 7Minematsu N, Nakamnura H,Iwata M, et al. Association of C YP2A6 deletion polymorphism with smoking habit and development of Pul- monary empysema [ J ]. Thorax,2003,58:623 - 628.
  • 8Tan W,Chen GF,Xing DY,et al. Frequency of CYP2A6 gene de- letionand its relation to risk of lung and esophageal cancer in the Chinese population[ J]. Int J Cancer,2001,95 (2) :96 - 101.
  • 9郭占林,周清华,朱文,李代蓉,袁天柱,王艳萍,陈晓禾,刘伦旭,伍伫,杨俊杰.代谢酶CYP2D6基因多态性与肺癌易感性的病例对照研究[J].中国肺癌杂志,2005,8(2):89-94. 被引量:7
  • 10王利花,王文明,杨敬平,斯琴高娃,孙春娟.CYP1A2基因多态性与COPD易感性的关系研究[J].临床肺科杂志,2012,17(9):1610-1612. 被引量:5

二级参考文献32

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2Sachse C, Brockmoller J, Bauer S, et al. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenoty-pic consequences. Am J Hum Genet,1997,60(2):284-295.
  • 3Yokota H, Tamura S, Furuya H, et al. Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism. Pharmacogenetics,1993,3(3):256-263.
  • 4Lee EJ, Jeyaseelan K. Frequency of human CYP2D6 mutant alleles in a normal Chinese population. Br J Clin Pharmacol,1994,37(6):605-607.
  • 5Gao Y, Zhang Q. Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese. Mutat Res,1999,444(2):441-449. Erratum in: Mutat Res,2000,464(2):311.
  • 6Ji L, Pan S, Wu J, et al. Genetic polymorphisms of CYP2D6 in Chinese mainland. Chin Med J (Engl),2002,115(12):1780-1784.
  • 7Armstrong M, Fairbrother K, Idle JR, et al. The cytochrome P450 CYP2D6 allelic variant CYP2D6J and related polymorphisms in a European population. Pharmacogenetics,1994,4(2):73-81.
  • 8Roh HK, Dahl ML, Johansson I, et al. Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population. Pharmacogenetics,1996,6(5):441-447.
  • 9Yokoi T, Kamataki T. Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese. Pharm Res,1998,15(4):517-524.
  • 10Ayesh R, Idle JR, Ritchie JC, et al. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature,1984,312(5990):169-170.

共引文献8246

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部